Cargando…
Su1490: COVID-19: A PREVALENCE RATE TWO TIMES LOWER THAN THAT OF THE GENERAL POPULATION IN FRENCH PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INTRAVENOUS BIOLOGIC AGENTS
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AGA Institute. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212297/ http://dx.doi.org/10.1016/S0016-5085(22)61412-4 |
| _version_ | 1784730551125540864 |
|---|---|
| author | Lelong, Margaux Nancey, Stephane Bouguen, Guillaume Allez, Matthieu Serrero, Mélanie Chupin, Antoine Caillo, Ludovic Viennot, Stephanie Blanc, Pierre Reimund, Jean-Marie Laharie, David olivier, Raphael Peyrin-Biroulet, Laurent Dib, Nina Maissin, Astrid de Montuclard, Celine Trang-Poisson, Caroline Gallot, Geraldine Bressollette-Bodin, Celine Berthome, Mathilde Burel, Marianne Vavasseur, Fabienne Bourreille, Arnaud Berre, Catherine Le |
| author_facet | Lelong, Margaux Nancey, Stephane Bouguen, Guillaume Allez, Matthieu Serrero, Mélanie Chupin, Antoine Caillo, Ludovic Viennot, Stephanie Blanc, Pierre Reimund, Jean-Marie Laharie, David olivier, Raphael Peyrin-Biroulet, Laurent Dib, Nina Maissin, Astrid de Montuclard, Celine Trang-Poisson, Caroline Gallot, Geraldine Bressollette-Bodin, Celine Berthome, Mathilde Burel, Marianne Vavasseur, Fabienne Bourreille, Arnaud Berre, Catherine Le |
| author_sort | Lelong, Margaux |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9212297 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AGA Institute. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92122972022-06-22 Su1490: COVID-19: A PREVALENCE RATE TWO TIMES LOWER THAN THAT OF THE GENERAL POPULATION IN FRENCH PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INTRAVENOUS BIOLOGIC AGENTS Lelong, Margaux Nancey, Stephane Bouguen, Guillaume Allez, Matthieu Serrero, Mélanie Chupin, Antoine Caillo, Ludovic Viennot, Stephanie Blanc, Pierre Reimund, Jean-Marie Laharie, David olivier, Raphael Peyrin-Biroulet, Laurent Dib, Nina Maissin, Astrid de Montuclard, Celine Trang-Poisson, Caroline Gallot, Geraldine Bressollette-Bodin, Celine Berthome, Mathilde Burel, Marianne Vavasseur, Fabienne Bourreille, Arnaud Berre, Catherine Le Gastroenterology AGA Abstracts AGA Institute. Published by Elsevier Inc. 2022-05 2022-06-16 /pmc/articles/PMC9212297/ http://dx.doi.org/10.1016/S0016-5085(22)61412-4 Text en Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | AGA Abstracts Lelong, Margaux Nancey, Stephane Bouguen, Guillaume Allez, Matthieu Serrero, Mélanie Chupin, Antoine Caillo, Ludovic Viennot, Stephanie Blanc, Pierre Reimund, Jean-Marie Laharie, David olivier, Raphael Peyrin-Biroulet, Laurent Dib, Nina Maissin, Astrid de Montuclard, Celine Trang-Poisson, Caroline Gallot, Geraldine Bressollette-Bodin, Celine Berthome, Mathilde Burel, Marianne Vavasseur, Fabienne Bourreille, Arnaud Berre, Catherine Le Su1490: COVID-19: A PREVALENCE RATE TWO TIMES LOWER THAN THAT OF THE GENERAL POPULATION IN FRENCH PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INTRAVENOUS BIOLOGIC AGENTS |
| title | Su1490: COVID-19: A PREVALENCE RATE TWO TIMES LOWER THAN THAT OF THE GENERAL POPULATION IN FRENCH PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INTRAVENOUS BIOLOGIC AGENTS |
| title_full | Su1490: COVID-19: A PREVALENCE RATE TWO TIMES LOWER THAN THAT OF THE GENERAL POPULATION IN FRENCH PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INTRAVENOUS BIOLOGIC AGENTS |
| title_fullStr | Su1490: COVID-19: A PREVALENCE RATE TWO TIMES LOWER THAN THAT OF THE GENERAL POPULATION IN FRENCH PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INTRAVENOUS BIOLOGIC AGENTS |
| title_full_unstemmed | Su1490: COVID-19: A PREVALENCE RATE TWO TIMES LOWER THAN THAT OF THE GENERAL POPULATION IN FRENCH PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INTRAVENOUS BIOLOGIC AGENTS |
| title_short | Su1490: COVID-19: A PREVALENCE RATE TWO TIMES LOWER THAN THAT OF THE GENERAL POPULATION IN FRENCH PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INTRAVENOUS BIOLOGIC AGENTS |
| title_sort | su1490: covid-19: a prevalence rate two times lower than that of the general population in french patients with inflammatory bowel disease treated with intravenous biologic agents |
| topic | AGA Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212297/ http://dx.doi.org/10.1016/S0016-5085(22)61412-4 |
| work_keys_str_mv | AT lelongmargaux su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT nanceystephane su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT bouguenguillaume su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT allezmatthieu su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT serreromelanie su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT chupinantoine su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT cailloludovic su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT viennotstephanie su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT blancpierre su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT reimundjeanmarie su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT lahariedavid su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT olivierraphael su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT peyrinbirouletlaurent su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT dibnina su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT maissinastridde su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT montuclardceline su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT trangpoissoncaroline su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT gallotgeraldine su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT bressollettebodinceline su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT berthomemathilde su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT burelmarianne su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT vavasseurfabienne su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT bourreillearnaud su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents AT berrecatherinele su1490covid19aprevalenceratetwotimeslowerthanthatofthegeneralpopulationinfrenchpatientswithinflammatoryboweldiseasetreatedwithintravenousbiologicagents |